the risk that the Emmaus common stocks and warrants will be delisted from The Nasdaq Capital Market, which could have a material adverse effect on the marketability and any trading prices of the …

More Emmaus Life Sciences Receives Notice of Nasdaq Delisting Following Merger with MYnd Analytics Videos